Meteorite logoMeteorite
Back to videos

What If We've Been Looking at Alzheimer's the Wrong Way?

Email: amonahan@alumni.stanford.edu Instagram: https://www.instagram.com/alexmonahan/ Twitter: https://x.com/AlexMonahaqyrt "I think we will solve Alzheimer's disease when we solve brain aging." Dr. Russell Swerdlow is a neurologist and Alzheimer's researcher at the University of Kansas. In 2004 he proposed the mitochondrial cascade hypothesis: the idea that the slow decline of mitochondria, the energy producers inside our cells, may sit upstream of the plaques, tangles and inflammation we associate with Alzheimer's. In this conversation he explains why he thinks the field has spent decades describing the disease without asking the most important question: why is it happening at all? We cover how the definition of Alzheimer's is changing, what "omics" studies of thousands of genes and proteins reveal, how AI can speed up research, and what he tells young people who carry a gene for early-onset Alzheimer's. He also makes a striking argument about modern medicine: we have become very good at destroying things (bacteria, viruses, tumor cells), but Alzheimer's will only be solved when we learn to repair what is broken. And then the biggest question of all: if we can stop the brain from aging, could we one day reverse it? His answer: "I wouldn't rule that out." CHAPTERS 0:00 Highlights 1:33 The full interview 2:08 Why he chose Alzheimer's: his grandmother's story 3:16 What's exciting in Alzheimer's research right now 3:36 Redefining Alzheimer's: plaques without memory loss 6:26 What is underexplored in Alzheimer's research? 7:48 "We will solve Alzheimer's when we solve brain aging" 9:36 Can AI speed up Alzheimer's research? 12:37 When will Alzheimer's be preventable? 14:29 Synapses, the immune system and mitochondria 15:30 Genetic testing and early-onset Alzheimer's 18:03 One cure for inherited and late-onset Alzheimer's? 19:18 Can we reverse brain aging? 20:06 Why medicine must learn to repair, not just destroy 21:18 Mitochondria, aging clocks and Alzheimer's genes 23:43 The blind men and the elephant 24:21 Closing thoughts KEY IDEAS FROM THE INTERVIEW • The field can now see amyloid plaques in the brain, on scans and even in blood tests. The next frontier is understanding why they form. • Large omics studies point to three big biological signals in Alzheimer's: synapses, the immune system and mitochondria. Dr. Swerdlow suspects mitochondria are driving the other two. • People born with deterministic mutations (APP, PSEN1, PSEN2) are healthy for decades, which suggests an aging "clock" is still involved, even in inherited Alzheimer's. • AI can compress months of research work into hours, but "garbage in, garbage out" still applies. • Prevention and treatment may be the same thing seen at different times: find what is breaking down and fix it early enough, and treatment becomes prevention. • Medicine excels at destroying what is broken. Neurodegenerative diseases will require the much harder task of repairing it. ABOUT DR. RUSSELL SWERDLOW Dr. Swerdlow is a neurologist at the University of Kansas Medical Center, where he leads research on how energy metabolism and mitochondria shape brain aging and Alzheimer's disease. He first proposed the mitochondrial cascade hypothesis of Alzheimer's in 2004 and published an updated version in 2023. He has been recognized with an Oskar Fischer Prize for new thinking on the causes of Alzheimer's. He also sees patients, including families affected by early-onset Alzheimer's. REFERENCES MENTIONED ON SCREEN • Revised criteria for diagnosis and staging of Alzheimer's disease: Jack et al., Alzheimer's & Dementia, 2024 • The Alzheimer's disease mitochondrial cascade hypothesis, an update: Swerdlow, Journal of Alzheimer's Disease, 2023 • Lecanemab (Leqembi) in early Alzheimer's disease: van Dyck et al., NEJM, 2023 • Donanemab (Kisunla) in early symptomatic Alzheimer's disease: Sims et al., JAMA, 2023 • Inherited early-onset Alzheimer's (APP, PSEN1, PSEN2): National Institute on Aging; Alzheimer's Association ABOUT THIS SERIES I'm Alex Monahan. I interview the scientists, doctors and patients working on Alzheimer's to understand what is working, what isn't, and what it will take to prevent this disease. Each video opens with highlights, then runs the full, unscripted interview. Do you think Alzheimer's will be preventable in your lifetime? Tell me in the comments. This video is for education only and is not medical advice. Talk to your own doctor about diagnosis, genetic testing and treatment options. #Alzheimers #BrainAging #Mitochondria #Dementia #Neuroscience #AlzheimersResearch #Longevity #Aging #BrainHealth #Neurology

Suggested videos